Product Information
HYDRALAZINE 50 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0445 per EA under NDC 50228018410. Its NADAC has been published 360 times since Nov 13, 2019.
FDA first approved this application on May 26, 2017. Its Orange Book therapeutic-equivalence code is AA.
Strength
50 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228018410
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDRALAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205236FDA Approved
5/26/2017
TE Code
AA
On Market Since
5/26/2017
Pharmacological Classes
Price Statistics
The NADAC for HYDRALAZINE 50 MG TABLET has been published 360 times since Nov 13, 2019, and over the history we have for it it has declined 17.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0445 per EA |
|---|---|
| All-time high | $0.0551 (Aug 12, 2020) |
| All-time low | $0.0343 (Nov 20, 2024) |
| 52-week high | $0.0475 |
| 52-week low | $0.0445 |
| Median price | $0.0477 |
| Average price | $0.0488 |
| Largest weekly change | -28.1% (Nov 20, 2024) |
| Weeks tracked | 360 |
| Tracking since | Nov 13, 2019 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ScieGen Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydralazine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Arteriolar Vasodilator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDRALAZINE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDRALAZINE 50 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0445 per EA (NDC 50228018410), effective Sep 30, 2026.
How has the price of HYDRALAZINE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDRALAZINE 50 MG TABLET has declined 17.7%. It has been tracked across 360 weekly CMS publications since Nov 13, 2019.
What are the highest and lowest recorded NADAC prices for HYDRALAZINE 50 MG TABLET?
Since Nov 13, 2019, the NADAC for HYDRALAZINE 50 MG TABLET has ranged from a low of $0.0343 (Nov 20, 2024) to a high of $0.0551 (Aug 12, 2020), with a median of $0.0477 per EA.
Are there cheaper alternatives to HYDRALAZINE 50 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDRALAZINE 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDRALAZINE 50 MG TABLET?
HYDRALAZINE 50 MG TABLET (NDC 50228018410) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.